Back

Which heart failure patients benefit from non-invasive telemedicine? An overview of current evidence

21 May 2023 (16:00 - 16:35)
Organised by: Logo
Congress Presentation Part of: e-Cardiology/digital health - remote patient monitoring and telehealth Remote Patient Monitoring and Telehealth HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Ms Jorna van Eijk

University Medical Center Utrecht, Utrecht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Effect of telemedicine on self-care in heart failure patients: insights from the iCOR randomised controlled trial
Doctor S. Yun Viladomat (Hospitalet De Llobregat, ES)
Abstract Slides
Presentation thumbnail
Performance of a multiparametric implantable cardioverter-defibrillator algorithm for heart failure risk stratification and management: the multicentric Spanish RE-HEART Registry
Doctor J. De Juan Baguda (Madrid, ES)
Abstract Slides
Presentation thumbnail
In-vitro model for continuous telemonitoring of left ventricular assist device (LVAD) using 5G networks (5G MedCamp project)
Mrs M. Hiddemann (Berlin, DE)
Abstract Slides
Presentation thumbnail
Effect of telemedicine on health-related quality of life in patients with heart failure: insights from the iCOR randomised controlled trial
Doctor S. Yun Viladomat (Hospitalet De Llobregat, ES)
Abstract Slides
Presentation thumbnail
An innovative smart auscultatory system to diagnose lung congestion from congestive cardiac failure: a proof of concept study
Associate Professor D. Foo (Singapore, SG)
Abstract Slides

Access the full session

Session thumbnail
e-Cardiology/digital health - remote patient monitoring and telehealth

The Event

Event poster

Heart Failure 2023

21 May 2023 16:00 CET
You may be interested in
thumbnail
Congress Session
How to implement a successful telemedicine program in heart failure
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Presentation
Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources